Episode #28: November 2020 – Compounding, Controlled Substances, and Legislative Agenda

from What, Why & How · host Iowa Pharmacy Association

Following the November 17 Board of Pharmacy meeting, IPA's Director of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss board action on the FDA’s memorandum of understanding regarding compounding, proposed rules impacting controlled substances and the PMP, and the Board’s legislative agenda.

Episode metadata supplied by the publisher feed · Published Nov 18, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode #28: November 2020 – Compounding, Controlled Substances, and Legislative Agenda

0:00 18:48

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of What, Why & How?

This episode is 18 minutes long.

When was this What, Why & How episode published?

This episode was published on November 18, 2020.

Can I download this What, Why & How episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!